Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
IMP9064 +/- Senaparib for Solid Tumors
Recruiting1 awardPhase 1
This trial is testing a new medicine called IMP9064, which may stop cancer cells from fixing their damaged DNA. It is aimed at patients with advanced solid tumors who need new treatment options. The medicine works by blocking proteins that help cancer cells repair themselves, making it harder for them to survive.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service